Tags

Type your tag names separated by a space and hit enter

Protein metabolism in Turner syndrome and the impact of hormone replacement therapy.
Clin Endocrinol (Oxf). 2007 Sep; 67(3):413-8.CE

Abstract

BACKGROUND

Studies have documented an altered body composition in Turner syndrome (TS). Body fat is increased and muscle mass is decreased. Ovarian failure necessitates substitution with female hormone replacement therapy (HRT), and HRT induces favourable changes in body composition. It is unknown how HRT affects protein metabolism.

AIM

To test whether alterations in body composition before and after HRT in TS are a result of altered protein metabolism.

DESIGN

We performed a randomized crossover study with active treatment (HRT in TS and oral contraceptives in controls) or no treatment.

MATERIALS AND METHODS

We studied eight women (age 29.7 +/- 5.6 (mean +/- SD) years) with TS, verified by karyotype, and eight age-matched controls (age 27.3 +/- 4.9 years). All subjects underwent a 3-h study in the postabsorptive state. Protein dynamics of the whole body and of the forearm muscles were measured by an amino acid tracer dilution technique using [(15)N]phenylalanine and [(2)H(4)]tyrosine. Substrate metabolism was examined by indirect calorimetry.

RESULTS

Energy expenditure was comparable among TS and controls, and did not change during active treatment. Whole-body phenylalanine and tyrosine fluxes were similar in the untreated situations, and did not change during active treatment. Amino acid degradation and protein synthesis were similar in all situations. Muscle protein breakdown was similar among groups, and was not affected by treatment. Muscle protein synthesis rate and forearm blood flow did not differ among groups or due to treatment.

CONCLUSION

Protein metabolism in TS is comparable to controls, and is not affected by HRT.

Authors+Show Affiliations

Medical Department M (Endocrinology and Diabetes) and Medical Research Laboratories, Aarhus Sygehus NBG, Aarhus University Hospital, Aarhus C, Denmark. ch.gravholt@dadlnet.dkNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Randomized Controlled Trial

Language

eng

PubMed ID

17561982

Citation

Gravholt, Claus Højbjerg, et al. "Protein Metabolism in Turner Syndrome and the Impact of Hormone Replacement Therapy." Clinical Endocrinology, vol. 67, no. 3, 2007, pp. 413-8.
Gravholt CH, Riis AL, Møller N, et al. Protein metabolism in Turner syndrome and the impact of hormone replacement therapy. Clin Endocrinol (Oxf). 2007;67(3):413-8.
Gravholt, C. H., Riis, A. L., Møller, N., & Christiansen, J. S. (2007). Protein metabolism in Turner syndrome and the impact of hormone replacement therapy. Clinical Endocrinology, 67(3), 413-8.
Gravholt CH, et al. Protein Metabolism in Turner Syndrome and the Impact of Hormone Replacement Therapy. Clin Endocrinol (Oxf). 2007;67(3):413-8. PubMed PMID: 17561982.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Protein metabolism in Turner syndrome and the impact of hormone replacement therapy. AU - Gravholt,Claus Højbjerg, AU - Riis,Anne Lene, AU - Møller,Niels, AU - Christiansen,Jens Sandahl, Y1 - 2007/06/11/ PY - 2007/6/15/pubmed PY - 2011/10/28/medline PY - 2007/6/15/entrez SP - 413 EP - 8 JF - Clinical endocrinology JO - Clin Endocrinol (Oxf) VL - 67 IS - 3 N2 - BACKGROUND: Studies have documented an altered body composition in Turner syndrome (TS). Body fat is increased and muscle mass is decreased. Ovarian failure necessitates substitution with female hormone replacement therapy (HRT), and HRT induces favourable changes in body composition. It is unknown how HRT affects protein metabolism. AIM: To test whether alterations in body composition before and after HRT in TS are a result of altered protein metabolism. DESIGN: We performed a randomized crossover study with active treatment (HRT in TS and oral contraceptives in controls) or no treatment. MATERIALS AND METHODS: We studied eight women (age 29.7 +/- 5.6 (mean +/- SD) years) with TS, verified by karyotype, and eight age-matched controls (age 27.3 +/- 4.9 years). All subjects underwent a 3-h study in the postabsorptive state. Protein dynamics of the whole body and of the forearm muscles were measured by an amino acid tracer dilution technique using [(15)N]phenylalanine and [(2)H(4)]tyrosine. Substrate metabolism was examined by indirect calorimetry. RESULTS: Energy expenditure was comparable among TS and controls, and did not change during active treatment. Whole-body phenylalanine and tyrosine fluxes were similar in the untreated situations, and did not change during active treatment. Amino acid degradation and protein synthesis were similar in all situations. Muscle protein breakdown was similar among groups, and was not affected by treatment. Muscle protein synthesis rate and forearm blood flow did not differ among groups or due to treatment. CONCLUSION: Protein metabolism in TS is comparable to controls, and is not affected by HRT. SN - 0300-0664 UR - https://www.unboundmedicine.com/medline/citation/17561982/Protein_metabolism_in_Turner_syndrome_and_the_impact_of_hormone_replacement_therapy_ L2 - https://doi.org/10.1111/j.1365-2265.2007.02902.x DB - PRIME DP - Unbound Medicine ER -